Consun Pharmaceutical Group (HKSE:01681) Scaled Net Operating Assets : 0.17 (As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Consun Pharmaceutical Group's operating assets for the quarter that ended in Jun. 2024 was HK$2,055 Mil. Consun Pharmaceutical Group's operating liabilities for the quarter that ended in Jun. 2024 was HK$1,059 Mil. Consun Pharmaceutical Group's Total Assets for the quarter that ended in Dec. 2023 was HK$6,025 Mil. Therefore, Consun Pharmaceutical Group's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.17.

Consun Pharmaceutical Group Scaled Net Operating Assets Historical Data

The historical data trend for Consun Pharmaceutical Group's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consun Pharmaceutical Group Scaled Net Operating Assets Chart

Consun Pharmaceutical Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.32

0.29

0.18

0.17

0.14

Consun Pharmaceutical Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.19	0.19	0.17	0.17	0.14

Competitive Comparison of Consun Pharmaceutical Group's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Consun Pharmaceutical Group's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Consun Pharmaceutical Group's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Consun Pharmaceutical Group's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Consun Pharmaceutical Group's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

Consun Pharmaceutical Group Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Consun Pharmaceutical Group's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(2105.295	-	1178.817)	/	5463.393
=	0.17

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	6024.528	-	3919.233
=	2105.295

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1738.323	-	4.264	-	555.242
=	1178.817

Consun Pharmaceutical Group's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(2054.73	-	1058.629)	/	6024.528
=	0.17

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	5910.084	-	3855.354
=	2054.73

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1613.496	-	3.872	-	550.995
=	1058.629

Consun Pharmaceutical Group Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Consun Pharmaceutical Group's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Consun Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (HKSE:01681) » Definitions » Scaled Net Operating Assets

Traded in Other Exchanges

C1P:Germany

Address

71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN

Website

https://www.chinaconsun.com

Consun Pharmaceutical Group Ltd is a biotechnology company with a modern pharmaceutical enterprise that integrates R&D, production, and marketing. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

Executives

Central Success Developments Limited	2101 Beneficial owner
Aali Resources Limited	2201 Interest of corporation controlled by you
Bos Trustee Limited	2301 Trustee
Assicurazioni Generali Spa	2201 Interest of corporation controlled by you
Gl China Long Equity Opportunities Fund Lp	2201 Interest of corporation controlled by you
Li Zhenfu	2201 Interest of corporation controlled by you
An Meng	2101 Beneficial owner
Zhang Lihua	2202 Interest of your spouse
Double Grace International Limited	2101 Beneficial owner
Li Qian	2101 Beneficial owner
An Yubao	2101 Beneficial owner
Bos Trustee Limited As Trustee	2201 Interest of corporation controlled by you

Consun Pharmaceutical Group Headlines

No Headlines